Big relief for those travelling abroad, Covaxin will get WHO approval this month

Spread the love

New Delhi: The indigenous Covid-19 vaccine Covaxin developed by Hyderabad-based Bharat Biotech may get the approval of the World Health Organization (WHO) this month. The WHO has so far approved emergency use of COVID vaccines developed by Pfizer-BioNTech, Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca.

Bharat Biotech has given the document in July itself

Covaxin is one of six vaccines approved for emergency use by India’s drug regulator. Covaccine is being used in the nationwide immunization programme. Apart from this, Covishield and Sputnik V are also being installed in India. The Center had told the Rajya Sabha in July that all the documents required for the WHO’s Emergency Use List (EUL) have been submitted by Bharat Biotech by July 9 and the WHO has started the review process.

Those travelling abroad will get relief

Confirming this, Dr NK Arora, President of the COVID Working Group, said, ‘We expect Covaxin to be included in the WHO’s EUL within this week.’ He said the vaccine should be given international recognition so that people travelling abroad do not face difficulties. Also, he said, the production of Covaxin will increase further in the coming days. The production of Covishield is also increasing.

WHO congratulated

Let us tell you, India has set a record of 75 crore vaccine doses, which is a big achievement in itself. In India, more than 10 per cent of people i.e. about 18 crore people have taken both doses. Whereas more than 30% i.e. more than 56.5 crores have taken a single dose. India has also been congratulated by WHO for this record.



Please enter your comment!
Please enter your name here